Should I buy or sell STERIS stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STE shares. View STE analyst ratings or view top-rated stocks .

What is STERIS's stock price target for 2024?

6 equities research analysts have issued 12 month target prices for STERIS's stock. Their STE share price targets range from $215.00 to $265.00. On average, they predict the company's stock price to reach $239.60 in the next year. This suggests a possible upside of 19.7% from the stock's current price. View analysts price targets for STE or view top-rated stocks among Wall Street analysts .

How have STE shares performed in 2024?

STERIS's stock was trading at $219.85 at the beginning of 2024. Since then, STE stock has decreased by 8.9% and is now trading at $200.24. View the best growth stocks for 2024 here .

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our STE earnings forecast .

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, February, 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.17 by $0.05. The medical equipment provider had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.35 billion. STERIS had a net margin of 10.48% and a trailing twelve-month return on equity of 13.67%. The company's revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.02 earnings per share. Read the conference call transcript .

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Tuesday, January 30th. Stockholders of record on Friday, February 23rd will be given a dividend of $0.52 per share on Friday, March 22nd. This represents a $2.08 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, February 22nd. Read our dividend analysis for STE .

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 1.02%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 21.85% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for STE .

What ETFs hold STERIS's stock?

ETFs with the largest weight of STERIS (NYSE:STE) stock in their portfolio include VanEck Environmental Services ETF (EVX) , iShares U.S. Medical Devices ETF (IHI) , BlackRock Future Health ETF (BMED) , Running Oak Efficient Growth ETF (RUNN) , Invesco S&P 500 Equal Weight Health Care ETF (RSPH) , Nuveen ESG Mid-Cap Value ETF (NUMV) , Invesco S&P 500 Equal Weight Health Care ETF (RYH) and First Trust Indxx Medical Devices ETF (MDEV) .

What guidance has STERIS issued on next quarter's earnings?

STERIS updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of 8.600-8.700 for the period, compared to the consensus earnings per share estimate of 8.670. The company issued revenue guidance of $5.5 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com . Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ) , Home Depot (HD) , AT&T (T) , Visa (V) , AbbVie (ABBV) , Abbott Laboratories (ABT) , Pfizer (PFE) , Gilead Sciences (GILD) , Mastercard (MA) and Medtronic (MDT) .

Who are STERIS's major shareholders?

STERIS's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.63%), Artemis Investment Management LLP (0.18%), Running Oak Capital LLC (0.05%), Perpetual Ltd (0.04%), Global Assets Advisory LLC (0.03%) and Czech National Bank (0.02%). Insiders that own company stock include Cary L Majors , Cynthia L Feldmann , Jacqueline B Kosecoff , John Adam Zangerle , Julia Madsen , Karen L Burton , Michael J Tokich , Mohsen Sohi and Renato Tamaro . View institutional ownership trends .

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:STE

STERIS (STE) Stock Price, News & Analysis

→ Your eBook: Mastering Earnings Announcements Trading (From StockEarnings) (Ad)

Free STE Stock Alerts

$200.06

-1.15 (-0.57%)

(As of 03:28 PM ET)

Compare

Today's Range: $198.40
▼
$200.99
50-Day Range: $204.00
▼
$236.03
52-Week Range: $180.54
▼
$254.00

Volume: 555,272 shs
Average Volume: 447,652 shs
Market Capitalization: $19.77 billion

P/E Ratio: 35.04
Dividend Yield: 1.04%
Price Target: $239.60

Get STERIS alerts:

STERIS MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 19.7% Upside
$239.60 Price Target
Short Interest: Bearish
2.72% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -2.00
Upright™ Environmental Score
News Sentiment: 0.60
Based on 14 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 9.80%
From $8.67 to $9.52 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.44 out of 5 stars

Medical Sector

103rd out of 930 stocks

Surgical Appliances & Supplies Industry

6th out of 18 stocks

2.3

Analyst's Opinion

Consensus Rating
STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.
Amount of Analyst Coverage
STERIS has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.72% of the float of STERIS has been sold short.
Short Interest Ratio / Days to Cover
STERIS has a short interest ratio ("days to cover") of 6.3.
Change versus previous month
Short interest in STERIS has recently increased by 2.29%, indicating that investor sentiment is decreasing.

4.2

Dividend Strength

Dividend Yield
STERIS pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
STERIS has been increasing its dividend for 19 years.
Dividend Coverage
The dividend payout ratio of STERIS is 36.43%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, STERIS will have a dividend payout ratio of 21.85% next year. This indicates that STERIS will be able to sustain or increase its dividend.

3.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
STERIS has received a 50.90% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Antiseptic hand rubs", "Medical endoscopes", and "Surgical masks" products. See details.
Environmental Sustainability
The Environmental Impact score for STERIS is -2.00.

2.0

News and Social Media Coverage

News Sentiment
STERIS has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 14 news articles for STERIS this week, compared to 6 articles on an average week.
Search Interest
Only 1 people have searched for STE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, STERIS insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.95% of the stock of STERIS is held by insiders.
Percentage Held by Institutions
94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for STERIS are expected to grow by 9.80% in the coming year, from $8.67 to $9.52 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of STERIS is 35.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.01.
Price to Earnings Ratio vs. Sector
The P/E ratio of STERIS is 35.07, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 184.89.
Price to Book Value per Share Ratio
STERIS has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad StockEarnings

Your eBook: Mastering Earnings Announcements Trading

Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).

Click Here to Claim Your FREE The Ultimate Strategy Guide To Trade Earnings E-Book .

About STERIS Stock (NYSE:STE)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

STE Stock News Headlines

April 14, 2024 | seekingalpha.com

Steris: Moving On, Losing Its Teeth

April 14, 2024 | americanbankingnews.com

STERIS (NYSE:STE) Receives Hold Rating from Needham & Company LLC

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

April 11, 2024 | bizjournals.com

Peak Rock Capital to buy Chicago manufacturer for $787.5 million

April 11, 2024 | prnewswire.com

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

April 11, 2024 | globenewswire.com

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

April 10, 2024 | finance.yahoo.com

GHX Celebrates 2023 Millennium Club Honorees for Supply Chain Automation

April 10, 2024 | msn.com

Gemini 1.5 Pro AI now supports audio prompts, but not for everyone

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

April 3, 2024 | msn.com

Microsoft is testing an Xbox AI chatbot that actually sounds useful

April 3, 2024 | msn.com

iPhone 16 Pro rumored to use a key design change from the iPhone 15

April 3, 2024 | finance.yahoo.com

Global Antiseptics and Disinfectants Market Size To Exceed USD 79.25 Billion By 2033 | CAGR of 10.67%

April 2, 2024 | markets.businessinsider.com

Quant Ratings Updated on 33 Stocks

March 20, 2024 | finance.yahoo.com

Those who invested in STERIS (NYSE:STE) five years ago are up 95%

March 13, 2024 | msn.com

Every Mistborn Book, Ranked From Worst To Best

March 12, 2024 | uk.finance.yahoo.com

Global Terminal Sterilization Services Market Report 2024-2034: Innovation, Outsourcing, and Regional Dynamics Driving Industry Growth

February 23, 2024 | finance.yahoo.com

Bioburden Testing Market is expected to reach USD 2.8 Billion by 2030, expanding at a 12.6% CAGR | MarketDigits

February 23, 2024 | news.yahoo.com

HCA North Florida Hospital says it has 'procured new instruments,' expanded staff

February 17, 2024 | seekingalpha.com

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

February 17, 2024 | finance.yahoo.com

There's A Lot To Like About STERIS' (NYSE:STE) Upcoming US$0.52 Dividend

February 16, 2024 | finance.yahoo.com

STE Mar 2024 190.000 call

February 12, 2024 | finance.yahoo.com

Why Steris (STE) is a Top Growth Stock for the Long-Term

February 10, 2024 | finanznachrichten.de

STERIS plc: STERIS Announces Financial Results for Fiscal 2024 Third Quarter

February 10, 2024 | msn.com

Bad News for Steris Stock: This New Risk Has Been Added

February 9, 2024 | markets.businessinsider.com

What 4 Analyst Ratings Have To Say About Steris

February 9, 2024 | finance.yahoo.com

STERIS plc (NYSE:STE) Q3 2024 Earnings Call Transcript

February 8, 2024 | finance.yahoo.com

STERIS (STE) Q3 Earnings Top Estimates, Fiscal '24 Sales View Up

See More Headlines

Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/07/2024
Ex-Dividend for 3/22 Dividend: 2/22/2024
Dividend Payable: 3/22/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:STE
CUSIP: 85915210
CIK: 1624899
Web: www.steris.com
Phone: (440) 354-2600
Fax: 440-639-4457
Employees: 17,100
Year Founded: 1987

Price Target and Rating

Average Stock Price Target: $239.60
High Stock Price Target: $265.00
Low Stock Price Target: $215.00
Potential Upside/Downside: +20.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): $5.71
Trailing P/E Ratio: 34.94
Forward P/E Ratio: 23.01
P/E Growth: N/A
Net Income: $107.03 million
Net Margins: 10.48%
Pretax Margin: 12.62%
Return on Equity: 13.67%
Return on Assets: 7.68%

Debt

Debt-to-Equity Ratio: 0.50
Current Ratio: 2.43
Quick Ratio: 1.49

Sales & Book Value

Annual Sales: $4.96 billion
Price / Sales: 3.98
Cash Flow: $18.46 per share
Price / Cash Flow: 10.81
Book Value: $61.31 per share
Price / Book: 3.25

Miscellaneous

Outstanding Shares: 98,810,000
Free Float: 97,875,000
Market Cap: $19.71 billion
Optionable: Optionable
Beta: 0.79

Social Links

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Daniel A. Carestio (Age 51)
President, CEO & Director
Comp: $1.59M
Mr. Michael J. Tokich (Age 55)
Senior VP & CFO
Comp: $838.61k
Mr. John Adam Zangerle (Age 57)
Senior VP, General Counsel & Secretary
Comp: $718.45k
Ms. Mary Clare Fraser (Age 54)
SVP & Chief Human Resources Officer
Comp: $555.75k
Mr. Cary L. Majors (Age 49)
Senior Vice President & President of Healthcare
Comp: $615.61k
Ms. Karen L. Burton (Age 56)
Chief Accounting Officer, VP & Controller
Julie Winter
Vice President of Investor Relations & Corporate Communications
Ms. Julia K. Madsen (Age 59)
Senior Vice President of Life Sciences
Mr. Andrew Xilas (Age 59)
Senior VP & GM of Dental
Comp: $1.44M
Kenneth E. Kohler
Senior VP & GM of AST

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy STERIS Stock? STE Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in STERIS plc:

STERIS plc reported earnings per share (EPS) of $2.22 for the last quarter, beating the consensus estimate by $0.05. This indicates strong financial performance and potential for growth.
The company has a market capitalization of $21.78 billion, showcasing its size and stability in the market.
STERIS plc operates in the surgical appliances & supplies industry, which has a consistent demand for its products and services, especially in healthcare settings.
Recent institutional investments from firms like Vanguard Group Inc. and BlackRock Inc. indicate confidence in the company's future prospects.
Despite a recent 3.7% decrease in stock price, STERIS plc has a 1-year high of $254.00, suggesting potential for stock price recovery and growth.

Cons

Investors should be bearish about investing in STERIS plc for these reasons:

The company's stock price recently experienced a 3.7% decline, indicating short-term volatility that may concern some investors.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STE Stock Analysis - Frequently Asked Questions

Should I buy or sell STERIS stock right now?: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STE shares.
View STE analyst ratings or view top-rated stocks.
What is STERIS's stock price target for 2024?: 6 equities research analysts have issued 12 month target prices for STERIS's stock. Their STE share price targets range from $215.00 to $265.00. On average, they predict the company's stock price to reach $239.60 in the next year. This suggests a possible upside of 19.7% from the stock's current price.
View analysts price targets for STE or view top-rated stocks among Wall Street analysts.
How have STE shares performed in 2024?: STERIS's stock was trading at $219.85 at the beginning of 2024. Since then, STE stock has decreased by 8.9% and is now trading at $200.24.
View the best growth stocks for 2024 here.
When is STERIS's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our STE earnings forecast.
How were STERIS's earnings last quarter?: STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, February, 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.17 by $0.05. The medical equipment provider had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.35 billion. STERIS had a net margin of 10.48% and a trailing twelve-month return on equity of 13.67%. The company's revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.02 earnings per share.
Read the conference call transcript.
How often does STERIS pay dividends? What is the dividend yield for STERIS?: STERIS announced a quarterly dividend on Tuesday, January 30th. Stockholders of record on Friday, February 23rd will be given a dividend of $0.52 per share on Friday, March 22nd. This represents a $2.08 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, February 22nd.
Read our dividend analysis for STE.
Is STERIS a good dividend stock?: STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 1.02%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 21.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What ETFs hold STERIS's stock?: ETFs with the largest weight of STERIS (NYSE:STE) stock in their portfolio include VanEck Environmental Services ETF (EVX), iShares U.S. Medical Devices ETF (IHI), BlackRock Future Health ETF (BMED), Running Oak Efficient Growth ETF (RUNN), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), Nuveen ESG Mid-Cap Value ETF (NUMV), Invesco S&P 500 Equal Weight Health Care ETF (RYH) and First Trust Indxx Medical Devices ETF (MDEV).
What guidance has STERIS issued on next quarter's earnings?: STERIS updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of 8.600-8.700 for the period, compared to the consensus earnings per share estimate of 8.670. The company issued revenue guidance of $5.5 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.
What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?: 196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.
What other stocks do shareholders of STERIS own?: Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).
Who are STERIS's major shareholders?: STERIS's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.63%), Artemis Investment Management LLP (0.18%), Running Oak Capital LLC (0.05%), Perpetual Ltd (0.04%), Global Assets Advisory LLC (0.03%) and Czech National Bank (0.02%). Insiders that own company stock include Cary L Majors, Cynthia L Feldmann, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi and Renato Tamaro.
View institutional ownership trends.
How do I buy shares of STERIS?: Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:STE) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial